Exhibit 99.1 Trinity Biotech plc Annual Report 2022 This report has been prepared in accordance with the Irish Companies Act 2014 TABLE OF CONTENTS Page Corporate Information 1 Market, Industry and Other Data 2 Cautionary Statement Regarding Forward-Looking Statements 2 Board of Directors & Executive Officers 3 Business Overview 4 Directors’ Report 7 Statement of Directors’ Responsibilities in respect of the annual report and the financial statements 18 Risk Factors 19 Performance Review 46 Independent Audi ...

Exhibit 99.1 Contact: Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Q1 2023 Financial Results DUBLIN, Ireland (July 6, 2023)... Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended March 31, 2023. Summary Highlights: Revenue/Margin: ...

SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...

Exhibit 99.1 Press Release dated March 23, 2023 Contact:Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results DUBLIN, Ireland (March 23, 2023)…. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended Dec ...

Trinity Biotech plc (NASDAQ:TRIB) Q4 2022 Earnings Conference Call March 23, 2023 10:00 AM ET Company Participants Joe Diaz - Lytham Partners, Investor Relations Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Operator Good morning and welcome to the Trinity Biotech Fourth Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] Aft ...

Corporate Presentation December 1, 2022 Nasdaq: TRIB ▲ Trinity Biotech Piper Sandler Healthcare Conference Disclaimer This presentation includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"), including but not limited to statements related to Trinity Biotech's cash position, financial resources and potential for future growth, market acceptance and penetration of new or planned product offerings, and futu ...

| --- | --- | |--------------------------------------|-------| | | | | POINT OF CARE \| CLINICAL LABORATORY | | | | | | | | | | | | | | | | | | | | | Your Diagnostics Partner | | | March 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nasdaq: TRIB | | Overview • Founded in 1992 – quoted on NASDAQ (TRIB) • Headquartered in Bray, Ireland (favourable tax regime – 12½% corporation tax) • Significant operations in the USA – direct salesforce; in addition to manufacturing operations in Buffalo, J ...